Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany —A retrospective analysis of real-world data

ConclusionDPP4i use was associated with a decrease in the risk of bone fracture.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research